Current Report Filing (8-k)
10 December 2022 - 8:32AM
Edgar (US Regulatory)
0001858912
false
0001858912
2022-12-07
2022-12-07
0001858912
tmb:UnitsEachConsistingOfOneShareOfCommonStockParValue0.0001PerShareAndOneRedeemableWarrantMember
2022-12-07
2022-12-07
0001858912
tmb:SharesOfCommonStockParValue0.0001PerShareIncludedAsPartOfUnitsMember
2022-12-07
2022-12-07
0001858912
tmb:RedeemableWarrantsIncludedAsPartOfUnitsMember
2022-12-07
2022-12-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
United
States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 9, 2022 (December 7, 2022)
GARDINER HEALTHCARE ACQUISITIONS CORP.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
|
001-41185 |
|
86-2899992 |
(State or other jurisdiction of
incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
3107 Warrington Road
Shaker Heights, Ohio |
|
44120 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (216) 633-6708
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange
on
which registered |
Units, each consisting of one share of common stock, par value $0.0001 per share, and one redeemable warrant |
|
GDNRU |
|
The Nasdaq Stock Market LLC |
Shares of common stock, par value $0.0001 per share, included as part of the units |
|
GDNR |
|
The Nasdaq Stock Market LLC |
Redeemable warrants included as part of the units |
|
GDNRW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01. Entry into a Material Definitive Agreement.
On December 7, 2022, Gardiner Healthcare Acquisitions Corp. (the “Company”)
issued a Third Amended and Restated Promissory Note (the “Promissory Note”) to Gardiner Healthcare Holdings, LLC, a
Delaware limited liability company (the “Lender”), one of the Company’s sponsors. The Promissory Note amends,
restates, replaces and supersedes that certain Second Amended and Restated Promissory Note dated December 13, 2021, as amended, in the
original principal amount of $300,000, executed by the Company in favor of Lender. Pursuant to the Promissory Note, the Lender agreed
to loan the Company up to an aggregate principal amount of $1,500,000. The Promissory Note is non-interest bearing and all outstanding
amounts under the Promissory Note will be due on the earlier of: (i) June 27, 2023, and (ii) the date on which the Company consummates
an initial business combination.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.
See the information set forth in Item 1.01 of this Current Report on
Form 8-K, which is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 8, 2022 |
GARDINER HEALTHCARE ACQUISITIONS CORP. |
|
|
|
|
By: |
/s/ Marc F. Pelletier |
|
Name: |
Marc F. Pelletier |
|
Title: |
Chief Executive Officer |
Gardiner Healthcare Acqu... (NASDAQ:GDNR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Gardiner Healthcare Acqu... (NASDAQ:GDNR)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Gardiner Healthcare Acquisition Corporation (NASDAQ): 0 recent articles
More Gardiner Healthcare Acquisitions Corp. News Articles